Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan’s Generic Advair Approval Showcases US FDA Efforts To Boost Complex Products

Executive Summary

Commissioner Gottlieb previews actions agency intends to take in 2019 to smooth the regulatory and scientific pathway for generics of complex drugs, including draft guidance with recommendations on establishing active ingredient sameness.

Advertisement

Related Content

Generic Advair's Labeling Variation Stems From Permissible Design Differences, US FDA Says
US FDA Weighs Patent Listing Requirements For Digital Apps Used With Drugs
Keeping Track: FDA Approves First Generic Advair, But Alkermes And Sunovion Land CRLs
Complex Generics: US FDA Heeds Some, But Not All, Of Industry’s Calls For Flexibility On Transdermal Products
Branded Advair Breathes Another Day; Mylan Says A CRL Is On The Way For A Generic
US FDA Releases Slew Of Guidances On A Fell Day For Complex Generics
Complex Generics: US FDA Still Wants Comparative Clinical Endpoint Studies For Inhaled, Nasal Drugs
Complex Generics: Gottlieb Eyes FDA Policy Changes To Speed Approvals
Complex ANDAs To Be Allowed Pre-Submission Product Meetings

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124671

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel